When Bonnie Markowitz was bitten by a tick in 1998, it took three months for doctors to identify her symptoms as Lyme disease. For some patients, the wait can be more than a year, a delay that experts ...
Discover how breastfeeding pressure impacts postpartum depression (PPD) and learn support strategies for moms struggling with ...
Is there really such a thing as human nature? The answer lies between two old extremes, and getting it right shapes how we face AI, authoritarianism, and climate.
AgeRejuvenation highlights advanced cellular plasma recharge in South Tampa to assist individuals overcoming chronic ...
June 29, 2026 Submitted by Amanda Cease for Cardinal Cushing Centers Jeff Bellows, who moved to Hingham in 2004 with his wife ...
It was produced both as a four-part television series for Makan, Israel’s Arabic-language public television channel, and as a ...
Genetic testing firm Natera and cancer drug ​developer Aveta Biomics said on Monday they have partnered ‌on a late-stage study of an experimental therapy for head and neck cancer, in a bid to improve ...
In this web exclusive for "Sunday Morning" viewers, six-time Grammy-winning singer-songwriter James Taylor performs his song ...
Investor's Business Daily on MSN
Germany's Merck KGaA swoops in with $11.3 billion medtech buyout
Germany's Merck KGaA pledged Thursday to buy Bio-Techne for $11.3 billion. The deal expands its portfolio of life sciences tools.
For an academic researcher who first trained as a philosopher, then as a psychologist, Robyn Dawes was a practical fellow. He would tell a story from his time working in a psychiatric ward in the ...
Three elementary school students from Port Washington have earned top national honors in the Securities Industry and ...
Investor's Business Daily on MSN
Natera flashes a buy signal. Why shares just leaped by double digits.
Natera stock narrowly broke out Wednesday after Japan's regulators approved its Signatera test to scan for colon cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results